SCHEMBL25063293

SCHEMBL25063293

CC(=O)Nc1cc(C(=O)O)ccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRSS12 P56730 4/20 0.41
▸ NEU3 Q9UQ49 1/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ CSNK2A2 P19784 6/20 0.39
▸ CSNK2A1 P68400 6/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NR1H4 Q96RI1 1/20 0.36
▸ POLQ O75417 1/20 0.36
▸ CCNE1 P24864 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ CDK5 Q00535 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ STAT3 P40763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24073688 0.87 STAT3 (0.47) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL27135495 0.83 IKBKE (0.41) PRSS12MEN1KMT2ACSNK2A2CSNK2A1
SCHEMBL24072387 0.82 KDM4E (0.44) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL29057074 0.81 STAT3 (0.59) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL30338919 0.81 STAT3 (0.59) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL24072280 0.79 SMN1; SMN2 (0.47) MEN1KMT2AALDH1A1RAB9AHPGD
SCHEMBL25063129 0.79 CSNK2A2 (0.53) MEN1KMT2ACSNK2A2CSNK2A1NPC1
SCHEMBL25063266 0.79 RAB9A (0.42) PRSS12NEU3MEN1KMT2AALDH1A1
SCHEMBL12697305 0.76 MEN1 (0.50) MEN1KMT2ACCNE1CDK2MAPT
SCHEMBL27135218 0.74 CYP1A2 (0.55) MEN1KMT2AALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 PRSS12 1949/4885NEU3 4449/4885MEN1 3254/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 PRSS12 1949/4885NEU3 4449/4885MEN1 3254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback